Enanta Pharmaceuticals, Inc. (ENTA) Stock Price & Growth Analysis

Quote Panel

Updated July 1, 2025

1W 3.36 % 1M 22.42 % 3M 45.28 % 1Y -42.75 %

Key Metrics

Market Cap
164.60M
Shares Outstanding
21.38M
Share in Float
19.86M
Dividende
0

Earning Date
04 Aug 2025
Price Target
7.7
Average Volume
188831
Beta
0.772

Range
4.09-17.235
Industry
Biotechnology
Website
https://www.enanta.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

2.54x

P/S Ratio

1.75x

P/B Ratio

0.6

Debt/Equity

-149.6%

Net Margin

$-4.5

EPS

How ENTA compares to sector?

P/E Ratio

Fundamentals

Relative Strength

ENTA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

ENTA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$63M

323%

2026-Revenue

$3.18

-200%

2026-EPS

$54M

-159%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

24.00(211.69%)

Number of analyst

Last analyst upgrade/downgrade

Evercore ISI

upgrade

Previous: Not converted

2022-07-06

Now: Outperform

Earnings Growth

YoY

Current

Estimates

Q2.23

N/A

-1.86
vs -1.53

Q3.23

N/A

-1.33
vs -1.27

Q4.23

N/A

-1.58
vs -1.39

Q1.24

N/A

-1.47
vs -1.79

Q2.24

N/A

-1.07
vs -1.86

Q3.24

N/A

-1.36
vs -1.33

Q4.24

N/A

-1.05
vs -1.58

Q1.25

N/A

-1.06
vs -1.47

Q2.25

N/A

-0.84
vs -1.07

Q3.25

N/A

-1.04
vs -1.36

Sales Growth

YoY

Current

Estimates

Q2.23

-3%

18.9M vs 19.5M

Q3.23

-7%

18.9M vs 20.3M

Q4.23

-24%

18M vs 23.6M

Q1.24

-4%

17.1M vs 17.8M

Q2.24

-5%

18M vs 18.9M

Q3.24

-23%

14.6M vs 18.9M

Q4.24

-6%

17M vs 18M

Q1.25

-12%

14.9M vs 17.1M

Q2.25

-10%

16.2M vs 18M

Q3.25

+0%

14.6M vs 14.6M

Return on Equity

QoQ

Q2.23

-16%

-0.16
vs -0.14

Q3.23

-13%

-0.13
vs -0.16

Q4.23

-17%

-0.17
vs -0.13

Q1.24

-19%

-0.19
vs -0.17

Q2.24

-15%

-0.15
vs -0.19

Q3.24

-22%

-0.22
vs -0.15

Q4.24

-20%

-0.20
vs -0.22

Q1.25

-24%

-0.24
vs -0.20

Institutionnal Ownership

QoQ

Q2.23

134

134
vs 147

-9%

Q3.23

132

132
vs 134

-1%

Q4.23

106

106
vs 132

-20%

Q1.24

108

108
vs 106

Q2.24

101

101
vs 108

-6%

Q3.24

111

111
vs 101

10%

Q4.24

107

107
vs 111

-4%

Q1.25

110

110
vs 107

Company Description

7.70USD

N/A

2.54x

1.75x

0.6

-149.6%

$-4.5

$63M

$3.18

$54M

Earnings Growth

Latest News

Company Description

7.70USD

N/A

2.54x

1.75x

0.6

-149.6%

$-4.5